Nasdaq stocks have been some of the hardest hit during the market downturn. In fact, over the last 12 months, the Nasdaq Composite Index has dropped more than 35%. This isn’t surprising, given the more growth-oriented nature of stocks listed on this exchange. Growth stocks are far more sensitive to interest rate increases, hence these types
0 Comments
In this article TSLA Follow your favorite stocksCREATE FREE ACCOUNT Ron Baron, founder of Baron Capital Anjali Sundaram | CNBC I began my career as a securities analyst in 1970. It was a tumultuous time. The Vietnam War, Watergate, the resignation of President Richard Nixon, the Iranian hostage crisis, a recession, inflation, interest rates in
0 Comments
Companies of all sizes appear to be hoarding cash for the much-discussed impending recession. If we do dive into a recession, cash-rich stocks will be more than prepared for whatever slowdown comes their way. However, when investing, it’s not enough to look for businesses with cash. They should also have limited debt and strong cash
0 Comments
Source: Shutterstock For the time being, Meta Materials (NASDAQ:MMAT) isn’t getting its due respect on Wall Street. The company has millions of dollars’ worth of purchase orders. Plus, its products have a wide variety of applications, meaning Meta Materials’ revenue should grow over time. As such, MMAT stock has the potential to go into the double
0 Comments
On today’s show, Preston and Stig bring back the CIO of CrowdStreet, Mr. Ian Formigle, who will talk about the COVID-19 impact on real estate. Ian has over 24 years of experience in the Real Estate market, while his company has over 400 offerings with over $13 billion in commercial real estate. IN THIS EPISODE,
0 Comments
In this article SBUX HSY CNK DKNG Follow your favorite stocksCREATE FREE ACCOUNT Check out the companies making headlines before the bell: DraftKings (DKNG) – DraftKings fell 12.5% in premarket trading despite reporting a smaller-than-expected quarterly loss and revenue that topped Wall Street forecasts. The sports betting company also raised its revenue guidance and warned
0 Comments
Based in New York, Mind Medicine (NASDAQ:MNMD) is a psychedelic-medicine developer that’s sometimes informally known as MindMed. Before investing in this company, it’s important to know that MNMD stock was previously out of compliance with the Nasdaq exchange’s listing requirements. This is a problem that could happen again in the near future. Moreover, Mind Medicine is
0 Comments
The selloff in tech stocks has gone from bad to worse. This earnings season has been a mess for the technology sector with numerous big-name companies coming up well short of expectations. Digital advertising has gone into a slump. On top of that, growth companies are cutting capital expenditure guidance, which implies further weakness in
0 Comments